Investigative Site

Canton, Ohio 44718

1 studies enrolling now · 2 studies all time

What they study most

End-Stage Renal Disease (ESRD), Tumor Hyperinsulinism (Tumor HI)

Studies at this site

• A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism — Recruiting now
• Dose Ranging Study of Dialysate Containing Soluble Iron to Treat Subjects With End Stage Renal Disease (ESRD) Receiving Chronic Hemodialysis — Completed